Silmitasertib sodium salt

Overview

Silmitasertib sodium salt is an orally bioavailable, highly selective and potent CK2 inhibitor, with IC 50 values of 1 nM against CK2α and CK2α'.

Application

Products | Products > Disease Areas > Viral Infection | Products > Disease Areas > SARS-CoV-2 Infection | Products > Disease Areas > Infection | Products > Disease Areas > Cancer | Products > Disease Areas > Coronavirus Infection | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Stem Cell/Wnt | Products > Signaling Pathways > Autophagy | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Stem Cells | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Casein Kinase | Products > Signaling Pathways > Autophagy

Product Information

• Catalog No.: HY-50855B
• CAS No.: 1309357-15-0
• Molecular Formula: C19H11ClN3NaO2
• Molecular Weight: 371.75
• Purity: 99.87%
• Storage: 4°C, sealed storage, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Solubility: ≥ 2.08 mg/mL (5.60 mM); Clear solution
• Availability: In-stock

Source

Original product source